I

Isomorphic Labs

AI-powered drug discovery and development

Principal Corporate Development

Venture CapitalConfirmed live in the last 24 hours
Full-timeLondon, UKNo salary listed

About the Job

Requirements

  • Degree or equivalent domain experience in a life-sciences-related field, with the ability to critically evaluate emerging biological and computational technologies.
  • Proven experience in Corporate Development, Venture Capital or Company Creation, or Life Sciences Investment Banking or Private Equity, with a demonstrated track record of leading transactions (M&A, minority equity investments, asset acquisitions, or joint ventures) from initial business case development to legal close.
  • Proven experience in valuation methodologies, creative deal structuring, and executive communication, with the ability to distil complex technical and commercial diligence into clear decision frameworks for senior leadership and key stakeholders.
  • Demonstrated ability to drive the operational rhythm of a lean, matrixed team by aligning technical, legal, finance, and business stakeholders through influence, maintaining high-hygiene pipeline reporting, and executing complex initiatives.
  • Proven track record in business partnering, influencing senior leadership, and stakeholder management.
  • Ability to independently build, exercise commercial judgment, and disqualify low-signal opportunities quickly.
  • Ability to analyse numbers while also contributing to broader commercial strategy and operational projects as the business scales.

Responsibilities

  • Proactively map the external landscape across digital biology, biotechnology, and enabling technologies to identify opportunities that accelerate the long-term roadmap.
  • Act as a first-pass technical and commercial filter by assessing scientific validity, technological differentiation, and strategic fit so internal R&D teams can focus on high-conviction opportunities.
  • Build and maintain trusted relationships with business partners across Machine Learning, R&D, and Commercial to evaluate complex inorganic opportunities and develop objective business cases.
  • Synthesize scientific, technical, and financial considerations into structured executive recommendations on whether to build, partner, invest, or acquire.
  • Self-direct and run corporate deals end-to-end, from business case development, valuation modeling, and term-sheet negotiation through due-diligence orchestration, definitive agreements, and closing governance.
  • Execute investments and innovative partnership structures that cultivate the broader tech-bio ecosystem, establish long-term strategic optionality, and align external innovation with the platform vision.
  • Evaluate inbound opportunities for alignment with long-term strategy and the broader business opportunity, and draft and present materials translating technical diligence into actionable executive recommendations.
  • Manage the day-to-day operational cadence of cross-functional corporate-development workflows; maintain pipeline tracking and executive reporting; coordinate and manage handoffs with Business Development and R&D; and build repeatable playbooks for transaction evaluation, diligence, and integration readiness.
  • Support broader Corporate Strategy and strategic initiatives through additional strategy and operational projects.

About the Company

Isomorphic Labs

AI-powered drug discovery and development

Isomorphic Labs uses artificial intelligence to speed up drug discovery and development. It applies machine learning and computational methods—building predictive and generative models—to accelerate how drugs are designed and how medical research is conducted. The company differentiates itself by combining the AI breakthroughs from Google DeepMind with Alphabet backing, enabling fast experimentation and scaling across biology while maintaining startup-style agility. Its goal is to bring safer, more effective therapies to market more quickly by advancing AI-driven medicine using deep learning, reinforcement learning, and other advanced techniques.

Company size
201-500
Company stage
Series C
Total funding
$7.7B
Headquarters
London, United Kingdom
Founded
2021

Recently Posted Jobs

Explore more opportunities at Isomorphic Labs

See more jobs